Mérieux Développement is the investment arm of French health care specialist, Institut Mérieux, which currently employs 15,000 staff worldwide and posted revenues of around €2.5 billion ($2.8bn) at the end of 2015 through its subsidiaries bioMérieux (listed on NYSE Euronext with the symbol BIM), Mérieux Nutrisciences and Transgene (NYSE Euronext, TNG). Mérieux Développement invests in the health and nutrition sectors and provides access to its expertise and its international network to support entrepreneurs and innovative companies whose products and services offer breakthroughs worldwide.
Mérieux Equity Partners is operating as a multi-stage investment manager, dedicated to evidence-based investment in companies that are developing superior products and services within the healthcare, life science and nutrition market segments. The flexibility of this strategy will allow Mérieux Equity Partners to not only provide private funding for promising venture companies, but also operate on cross-over financings, IPOs, and offer significant equity financing to fast-growing and profitable companies within the space when they get more established.
Founded in 1997, Financière Arbevel is an independent management company that has experienced very strong growth since it was taken over in 2009 by MM. Lalevée and Delabare. Currently managing 1.8 billion euros, the company employs 34 people, 13 of whom are dedicated to management and research.
Launched at the end of 2018, the Arbevel Life Sciences Crossover I fund is the first private equity vehicle within Financière Arbevel. With around thirty million euros at the first closing (the second is scheduled for the end of 2019), the fund has already made 4 investments (NG Biotech, NH TherAguix, Keranova and TransCure bioServices).
CEA Investissement is a subsidiary of the French Alternative Energies and Atomic Energy Commission (CEA), focusing specifically on financing for high tech businesses. Its investments are supported by two funds: the CEA Strategic Fund and the ATI Fund, which are subscribed by CEA, Bpifrance, energy company EDF, international high tech corporation Safran and Biomérieux. Since it was founded, CEA Investissement has provided funding to over 50 companies operating in microelectronics, the life sciences, energy and the environment, as well as in materials, instrumentation and on-board systems for industry. The CEA Investissement team is split between Grenoble and Paris.
Supernova Invest is an independent venture capital firm that has strong relationships with the CEA, one of the world’s leading research organisations and with Amundi, the largest asset manager in Europe. Investments focus on companies developing disruptive innovations operating in the life sciences, energy & environment, industrial, microelectronics and digital sectors. Today, Supernova Invest manages or advises 5 funds totalling 250 million euros and has invested in more than a 100 start ups since 1999. Supernova Invest is based in France.
TI-invest is a family investment fund, created in 2006 following the sale of IOLTECH laboratory (implants and ophthalmic medical devices) at Zeiss AG group. Since its creation, TI-invest has invested in various fields including health with ZEISS, Hemarina and Keranova.
Bpifrance, a subsidiary of the Caisse des Dépôts et de l’État (a French public financial institution) and reliable partner for entrepreneurs from start-up to listing on the stock market, credit, guarantees and shareholder equity. Bpifrance also provides coaching and support for innovation, external growth and export in partnership with Business France and Coface. With more than 40 regional locations, companies that work with Bpifrance have a powerful, local and effective partner who can meet all their funding, innovation and investment needs.
With a window on the socioeconomic world, the Université Jean-Monnet (UJM) is home to 20,000 students and plays a crucial role in the region. It extends from Saint-Etienne to Roanne, encompassing five campuses, and is strongly committed to the development of the Lyon-St.Etienne metropolitan area with its Community of Universities and Institutions (COMUE – Université de Lyon). UJM continues to strengthen its position in health-related teaching and research. It is a renowned for its pioneering and innovation, and is one of five French universities to include health as a component of its multidisciplinary programs. UJM was selected by the French Ministry of Higher Education and Research to experiment with new ways to access the study of medicine.
The metropolitan area of Saint-Etienne Métropole supports business development by offering local services tailored to the needs of a range of business activities. The infrastructure of Saint Etienne Métropole creates a favorable environment for new businesses to set up and and create local jobs.
Auvergne-Rhône-Alpes Region: KERANOVA® is pleased to acknowledge the support of the AURA Regional Economic Agency which guides and supports industrial companies and services at all stages of development including investment, training and employment, innovation, export, and applying for the funding of European projects.
Auvergne-Rhône-Alpes Entreprises is also responsible for promoting the Auvergne-Rhône-Alpes region internationally and using its many strengths to attract new businesses.